Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA StudyYasunori Murata, Nobuhiko Seki, Toshihiro Misumi et al.|JTO Clinical and Research Reports|2023Cited by 5